ASB8 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 1.769040E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
9.621200E-01
Normal-vs-Stage2
6.780200E-02
Normal-vs-Stage3
1.067410E-01
Normal-vs-Stage4
6.376800E-01
Stage1-vs-Stage2
9.321000E-03
Stage1-vs-Stage3
1.307650E-01
Stage1-vs-Stage4
5.684600E-01
Stage2-vs-Stage3
5.744200E-01
Stage2-vs-Stage4
3.229000E-01
Stage3-vs-Stage4
4.443600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
1.842030E-01
Normal-vs-AfricanAmerican
3.563400E-01
Normal-vs-Asian
1.091770E-01
Caucasian-vs-AfricanAmerican
6.669600E-01
Caucasian-vs-Asian
4.345200E-01
AfricanAmerican-vs-Asian
3.781200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
1.567000E-01
Normal-vs-Female
2.175800E-01
Male-vs-Female
7.338800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
9.235400E-01
Normal-vs-Age(41-60Yrs)
3.900400E-01
Normal-vs-Age(61-80Yrs)
9.816500E-02
Normal-vs-Age(81-100Yrs)
1.540430E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
4.950400E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
1.448990E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
2.670000E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
1.393970E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
3.320000E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
7.555800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
7.423200E-03
Normal-vs-Daily Drinker
7.063700E-02
Normal-vs-Weekly Drinker
8.128400E-02
Normal-vs-Occasional Drinker
6.232600E-01
Normal-vs-Social Drinker
5.005000E-01
Non Drinker-vs-Daily Drinker
5.810400E-01
Non Drinker-vs-Weekly Drinker
7.988800E-01
Non Drinker-vs-Occasional Drinker
2.687600E-02
Non Drinker-vs-Social Drinker
1.097190E-01
Daily Drinker-vs-Weekly Drinker
8.549800E-01
Daily Drinker-vs-Occasional Drinker
6.687900E-02
Daily Drinker-vs-Social Drinker
1.877970E-01
Weekly Drinker-vs-Occasional Drinker
9.278200E-02
Weekly Drinker-vs-Social Drinker
2.126800E-01
Occasional Drinker-vs-Social Drinker
7.202600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
9.481700E-02
Normal-vs-Grade 2
4.011500E-02
Normal-vs-Grade 3
2.860300E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
4.323800E-02
Grade 1-vs-Grade 3
3.220400E-02
Grade 1-vs-Grade 4
9.481700E-02
Grade 2-vs-Grade 3
7.276600E-01
Grade 2-vs-Grade 4
4.011500E-02
Grade 3-vs-Grade 4
2.860300E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
1.071580E-01
Normal-vs-NonDiabetic
1.528170E-01
Diabetic-vs-NonDiabetic
7.290000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
1.863890E-02
Normal-vs-NoPancreatitis
1.543800E-01
Pancreatitis-vs-NoPancreatitis
1.826640E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
3.481800E-01
Normal-vs-N1
7.592100E-02
N0-vs-N1
2.871400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
1.075010E-01
Normal-vs-TP53-NonMutant
7.579200E-01
TP53-Mutant-vs-TP53-NonMutant
8.369800E-04
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
